© 2003 by BMJ Publishing Group & British Cardiac Society
VIEWPOINT
C reactive protein for risk stratification in acute coronary syndromes? Verdict: unproven
1 Department of Cardiology, Barts and the London NHS Trust, London, UK
2 Department of Cardiology, St Vincents Hospital, Melbourne, Australia
Correspondence to:
Correspondence to:
Dr Simon Kennon, Department of Cardiology, London Chest Hospital, Bonner Road, London E2 9JX, UK;
srok{at}dircon.co.uk
Although C reactive protein is intimately involved with the pathogenic mechanisms that drive acute coronary syndromes, there is no evidence that it is helpful for identifying patient groups who might benefit from particular treatment strategies
Keywords: C reactive protein; inflammation; acute coronary syndromes; troponin
Abbreviations: CAPTURE, chimeric 7E3 antiplatelet therapy in unstable angina refractory to standard treatment; CRP, C reactive protein; FRISC, Fragmin during instability in coronary artery disease; IL, interleukin; TIMI, thrombolysis in myocardial infarction
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
De Servi, S., Mariani, M., Mariani, G., Mazzone, A.
(2005). C-Reactive Protein Increase in Unstable Coronary Disease: Cause or Effect?. J Am Coll Cardiol
46: 1496-1502
[Abstract] [Full Text] -
Panteghini, M.
(2004). Role and importance of biochemical markers in clinical cardiology. Eur Heart J
25: 1187-1196
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
